Zuraiz Chaudhary - 17 Nov 2025 Form 4 Insider Report for Turn Therapeutics Inc. (TTRX)

Role
Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer.
Signature
/s/ Zuraiz Chaudhary
Issuer symbol
TTRX
Transactions as of
17 Nov 2025
Net transactions value
+$9,050
Form type
4
Filing time
17 Nov 2025, 21:23:35 UTC
Previous filing
23 Oct 2025
Next filing
21 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chaudhary Zuraiz Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer. C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE /s/ Zuraiz Chaudhary 17 Nov 2025 0002086494

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTRX Common Stock Purchase $9,050 +2,500 +50% $3.62 7,550 17 Nov 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.50 to $3.69, inclusive. The Reporting Person undertakes to provide to Turn Therapeutics Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Remarks:

Interim Chief Financial Officer, Vice President of Finance & Chief Accounting Officer.